Ology and Just - Evotech Collaborate to Develop Antibodies Against Coronavirus Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention of infection with Sars-CoV-2 Just – Evotec Biologics to supply antibody screening and analytical characterization of anti-covid-19 antibodies
The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract valued at $27.3 million to Ology Bioservices Inc...
D. M. Berrie, R. C. Waters, C. Montoya, et al. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor. Vaccine, https://doi.org/10.1016/j.vaccine.2020.03.041 Read More >
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense...
Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. BioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137 Read More >
Government Contracts For Biodefense: The Benefits and Risks. Robert V. House, PhD, FATS, Senior Vice President of Government Contracts at Ology Bioservices shares his thoughts on the benefits of Government Contracting in an article recently published in the Washington Business Journal. Read it here
CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate Public Health Vaccine, LLC. will partner with Crozet Biopharma to develop the Nipah vaccine candidateUp to $9 million of this funding will go to Ology Bioservices, Inc., to support manufacturing and stockpiling of [...]
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc. PRESS RELEASE UPDATED: AUG 7, 2019 CINCINNATI, August 7, 2019 (Newswire.com) - Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with Ology Bioservices, Inc. to manufacture a novel universal influenza vaccine. The vaccine, based on technology [...]
Privacy Policy Website Privacy Policy Ology Bioservices, Inc. Revised as of 21stJune 2019 By visiting our website, you are accepting the practices described in this Privacy Policy We have created this privacy policy to demonstrate our firm commitment to the privacy of our visitors and customers. We are committed to respecting [...]
COVID-19 Letter